Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SPG✓SelectedUSD · SPGGSK vs SPG performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs SPG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
SPG return
+82.9%
Excess return
-39.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioSPGExcessAlpha
1D-2.3%-1.1%-1.2%-2.1%
7D-3.0%-1.8%-1.2%-2.6%
30D+0.4%+12.1%-11.7%-2.2%
3M-1.2%+5.0%-6.2%-2.3%
6M+0.9%+17.6%-16.7%-2.6%
YTD+4.0%+28.6%-24.6%-1.4%
1Y+7.3%+33.1%-25.8%+1.1%
3Y+57.1%+119.2%-62.1%+33.9%
5Y+43.0%+79.3%-36.4%+21.2%
All+43.0%+82.9%-39.9%+21.2%

Cumulative growth

Daily Returns

Daily percentage return beside SPG.

Daily Out/Under-Performance

Portfolio return minus SPG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SPG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded SPG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling